Neuralink wants to automate brain surgery and mass produce implants by 2026
SMRTR summary
Neuralink plans to mass-produce brain-computer interface implants and implement fully automated surgery by 2026, marking a shift from clinical trials to commercial deployment. After successfully testing devices on 12 paralyzed patients who can control computers through thought alone, the company secured $650 million in funding to scale production while maintaining surgical precision through robotic automation.
SMRTR provides this summary for quick context. The original article belongs to TechSpot.
Read the original article